Pharming (PHAR) Tax Provisions (2020 - 2026)
Pharming (PHAR) posted Tax Provisions of -$459000.0 for Q1 2026, up 95.55% on a QoQ basis from -$10.3 million in Q4 2025, and up 85.19% year-over-year from -$247848.8 in Q1 2025.
Pharming (PHAR) Tax Provisions (2020 - 2026) Analysis & Trends
Pharming's Tax Provisions history runs 7 years deep, the most recent figure standing at -$459000.0 for Q1 2026.
- Quarterly Tax Provisions rose 85.19% year-over-year to -$459000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$16.4 million (down 377.94% YoY) and the FY2025 annual result came in at $10.3 million, up 207.85% from the prior year.
- Tax Provisions was -$459000.0 for Q1 2026 at Pharming, up from -$10.3 million in the prior quarter.
- Across five years, Tax Provisions topped out at $4.5 million in Q1 2023 and bottomed at -$10.3 million in Q4 2025.
- A 5-year average of -$985529.9 and a median of -$200000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions jumped 658.25% — and 2024, when it tumbled 328.76%.
- Pharming's Tax Provisions stood at -$4.8 million in 2022, then surged by 130.5% to $1.5 million in 2023, then tumbled by 328.76% to -$3.3 million in 2024, then sank by 207.85% to -$10.3 million in 2025, then soared by 95.55% to -$459000.0 in 2026.
- Business Quant data shows PHAR's Tax Provisions at -$459000.0 in Q1 2026, -$10.3 million in Q4 2025, and -$5.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Pharming | 8.69 Bn | 8.64 Bn | 65.80 Mn | -459,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -459,000.00 |
| Dec 31, 2025 | -10.31 Mn |
| Sep 30, 2025 | -5.20 |
| Jun 30, 2025 | -5.63 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -3.35 Mn |
| Sep 30, 2024 | -2.50 |
| Jun 30, 2024 | 3.02 Mn |
| Mar 31, 2024 | 4.18 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 157,000.00 |
| Jun 30, 2023 | 2.40 Mn |
| Mar 31, 2023 | 4.47 Mn |
| Dec 31, 2022 | -4.80 Mn |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -3.79 Mn |
| Mar 31, 2022 | -800,000.00 |
| Dec 31, 2021 | 7.07 Mn |
| Sep 30, 2021 | -1.75 Mn |
| Jun 30, 2021 | -1.37 Mn |